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ABSTRACT 
An abstract of the project paper presented to the Faculty of Veterinary Medicine, 
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Faculty: Veterinary Medicine 
A study was carried out to determine the prevalence of Equine Infectious Anemia 
Virus (EIAV) among horses of various clubs in the state of Selangor. A total of 94 
serum samples was obtained from horses of various breeds, sex and age and tested 
for the presence of antibodies against EIAV using; (i) competitive enzyme-linked 
immunosorbent assay (CELISA) and (ii) agar gel immunodiffusion (AGID) test, to 
demonstrate the presence of antibodies against p26 recombinant gag protein. All 
horses sampled in this study were kept in stables and have access to paddock grazing. 
Horses have no history of contact with imported stocks. In this study none of the 
sera had antibodies against EIA virus. It is possible that the strict import policies 
imposed, and the almost non-existent importation of horses for the purpose of 
breeding has prevented the introduction of the disease into Malaysia. 
ABSTRAK 
Abstrak daripada kertas projek yang dibentangkan 
kepada Fakulti Perubatan Veterinar, Universiti Putra Malaysia adalah sebahagian 
daripada keperluan memenuhi Ijazah Sarjana dalam Perubatan Veterinar 
KAJI SELIDIK SEROLOGI TERHADAP VIRUS ANEMIA BERJANGKIT 
KUDA (EIAV) KE ATAS KUDA-KUDA DI SELANGOR 
Oleh 
ABDUL NASSER ASHOUR ALTAEB 
Mac 2004 
Penyelia : Dr. Mohd Azam Khan Goriman Khan 
Fakulti: Perubatan Veterinar 
Satu kajian telah dijalankan untuk mengkaji prevalens virus anaemia berjangkit 
ekuin (EIAV) di kalangan kuda-kuda dari berbagai kelab di negeri Selangor. 
Sejumlah 94 sampel serum telah diambil dari kuda-kuda pelbagai baka, jantina dan 
umur, dan telah diuji untuk menentukan kehadiran antibodi-antibodi terhadap EIAV 
dengan menggunakan (i) asai imunoerap terangkai enzim bersaing (CELISA) dan 
(ii) ujian imunoresapan gel agar-agar (AGID) untuk menunjukkan kehadiran 
antibodi-antibodi terhadap rekombinan protein gag p26. Semua kuda-kuda yang di 
sampel dalam kajian ini disimpan di dalam kandang dan dibenarkan melakukan 
ragutan alongan. Kuda-kuda terlibat tidak pernah di dalam sejarah bersentuh dengan 
stok-stok yang di import. Di dalam kajian ini tiada satu pun serum-serum yang diuji 
mengandungi antibodi terhadap virus EIA. Kemungkinan polisi-polisi ketat 
pengimportan yang dikuatkuasakan dan hampir tiadanya pengimportan kuda-kuda 
untuk tujuan pembiakan, telah mencegah kemasukan penyakit tersebut ke Malaysia. 
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CHAPTER 1 
INTRODUCTION 
Equine infectious anemia (EIA) or Swamp Fever is a multisystemic retroviral 
disease of equidae, characterized by hemolytic anemia that is immune mediated 
(Clabough, 1990). The disease is caused by Equine infectious anemia virus (EIAV), 
a member of the lentivirus subfamily of retroviruses. The virus possesses the surface 
glycoproteins, gp90 and gp45 and four major nonglycosylated internal core proteins, 
known as p26, p15, p l l  and p9 (Parekh et al., 1980; Montelaro et al., 1984; Hussain 
et al., 1988) (Appendix 2). 
The disease is distributed worldwide in the Equidae family; and has been 
reported in horses, donkeys and mules (Montelaro et al., 1984; Hammond et al., 
1997). Once an animal is infected, it will remain infected for the rest of its life 
(Montelaro et al., 1984; Clements and Zink, 1996; Issel et al., 1982). 
After infection, the animal experiences three distinct disease phases: acute, 
chronic and inapparent carrier (Clabough, 1990; Roberts and Lucas, 1987). The acute 
stage of infection is characterized by recurrent febrile episodes with high virus load. 
After resolution of the primary viremia, most animals develop chronic EIA, which is 
characterized by recurrent cycles of the disease, associated with weight loss and 
anemia, leading to a prolonged and symptomatic period, and finally an inapparent 
carrier stage for the rest of the animal's life (Hammond et al., 1997). 
Most infected horses develop a vigorous humoral immune response, the 
envelope glycoproteins being the major immunogens. Each episode of viremia is 
associated with the appearance of a new and predominant antigenic variant of the 
virus; caused by point mutations in the env gene that codes the viral surface proteins 
(Montelaro et al., 1984). 
Although EIA infection persists life-long, during non-fibrile intervals the 
likelihood of isolating EIA from blood samples is close to nil. The diagnosis of EIA 
rests entirely on serological evidence (Issel et al., 1988). Coggins et al., (1972) 
developed an agar gel immunodifision (AGID) test to detect precipitating 
antibodies to the core protein p26, which is known to be group-reactive and 
antigenically stable (Payne et al., 1984). The AGID test is the only test officially 
recognized by the Office International des Epizooties (01E) in Paris (Pearson and 
Coggins, 1979). A positive AGID test noted 15 to 25 days post infection (Coggins et 
al., 1972), confirms that the virus is present as infected horses produce antibodies to 
EIAV proteins within 12 days of infection (Issel and Cook, 1993). 
Enzyme-linked immunosorbent assay (ELISA) was developed in the late 
1980's for faster and more sensitive serodiagnosis (Issel et al., 1988; Archambault et 
al., 1989; Ramachandran et al., 1990). Competitive ELISA (CELISA) was 
developed using purified antigens from cell culture adapted EIAV strain Wyoming, 
to detect antibodies against p26 protein. Although the authors found a good 
correlation between AGID and CELISA, the latter could not detect weak positive 
antibody titers (Burki et al., 1992; Issel and Cook, 1993). Another ELISA was 
developed using the amino-terminal portion of a recombinant gp45 protein as antigen 
(Hancock and Tsang, 1986; Archambault et al., 1989; Thomas et al., 1991; Lew et 
al., 1993). Soutullo et al., (2001) designed an ELISA test using linear and cyclic 
synthetic peptides from gp45 and gp90 as antigen. To date, the largest amount of 
serological information relating to the presence of EIAV infection has been obtained 
using the internal core protein p26 and surface glycoprotein gp90 and gp45 isolates 
as the antigens. 
Since clinical diagnosis is difficult for acute and inapparent infection, the 
movement of horses across borders stands the risk of causing economic 
embarrassments and interference to sporting events due to EIA. Economic losses 
due to the disease can be large as there is no treatment or vaccination, for this 
disease. Mortality rates may approach 50% and the athletic ability of horses 
reduced. 
Serologic evidence for EIAV infection has been reported in many countries 
around the world. Using AGID and CELISA the prevalence of this disease was 1.5- 
2.5% in the USA, 6% in Canada, a low level in France, 1.6% in West Germany, and 
15-25% in Argentina and 50% in Brazil. The disease has never been recorded in 
Malaysia. Large-scale movements of horses during wartime have been responsible 
for extensive dissemination of the disease. At the present time there is another surge 
of infection in most countries, possibly due to obligatory testing conducted as 
surveillance of the disease. It is suggested that the rapid expansion of 'pleasure 
horses' activity in affluent countries leads to more movement and opportunities for 
spread of the infection from relatively few donors (Coggins, 1984). 
Since there are no records on EIAV seroprevalence among horses in 
Malaysia, the objective of this study was to investigate the seroprevalence of Equine 
Infectious Anemia (EIA) among horses in Selangor using two different methods, 
Competitive Enzyme Linked Imunosorbent Assay and Agar Gel Immunodiffusion 
(Coggins Test). 
CHAPTER 2 
LITERATURE REVIEW 
2.1 Retroviruses 
In 1981 the center for disease control (CDC) USA, first described the 
symptoms of disease that would be identified later as acquired immune deficiency 
syndrome (AIDS). AIDS caused by a retrovirus infect other animals such as rodents, 
monkeys, and horses. Nineteen years after the isolation of the human 
immunodeficiency virus (HIV), the etiology agent of AIDS, the World Health 
Organization (WHO) estimates 65 million people to be infected with HIV world 
wide, thus establishing HIV as the leading cause of death by infectious agents. 
The impact of HIV has greatly changed the direction of scientific research 
and brought the field of retrovirology to the forefront of medicine. The Retroviridae 
family includes viruses with a diploid RNA genome that utilizes reverse 
transcriptase, an RNA dependent DNA polymerase. Retroviruses are enveloped 
viruses ranging in size from 80-100 nm in diameter and contain the enzymes reverse 
transcriptase integrase and protease (Coffin et al., 1997). 
2.2 Retrovirus Genome and Proteins 
As reviewed by Coffin et al., (1997) the retrovirus family can be divided in two 
main groups, based on genome organizations, simple and complex; Simple 
retroviruses have gag, pro, pol and env genes that encode polyproteins. The gag 
gene encodes the mature capsid (CA), matrix (MA), and nucleocapsid (NC) 
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structural proteins. The pol encodes reverse transcriptase (RT), and integrase (IN). 
The gag and pol polyproteins are proteolyticlally cleaved via viral protease, encoded 
by the Pro gene. The env gene encodes the surface (SU) and transmembrane (TM) 
outer structure proteins. The env polyprotein is cleaved by host cell proteases. The 
retrovirus provirus also contains non-coding long terminal repeats (LTR) located at 
the 5'and 3' ends. The LTR consists of U3 (unique 3') and U5 regions. The U3 
element occurs once at 3' end of viral genomic RNA and twice in proviral DNA. 
The U3 region is between 120 - I200 nucleotides in length. 
2.3 Lentiviruses 
The term lentivirus originates from the Latin world lenti meaning slow. This 
sub group of retroviruses is named due to the long incubation period from initial 
infection with the virus, to appearance of disease symptoms. Viruses in the 
lentiviruses group of retroviruses are the human immunodeficiency virus (HIV-1 and 
HIV-2), simian immunodeficiency viruses (SIVS), equine infectious anemia virus 
(EIAV), bovine immunodeficiency virus (BIV), visna virus or caprine arthritis 
encephalitis virus (CAEV), and feline immunodeficiency virus (FIV). EIAV and 
other lentiviruses encods a dUTPase enzyme (designated DU), which maps to the pol 
gene (McClure et al., 1988: Elder et al., 1992). 
2.4 Equine Infectious Anemia Virus (EIAV) 
In vitro, several strains of EIAV have been shown to infect and replicate in 
feline embryonic cells (FEA), canine osteosarcoma cells (CF12h), and equine 
macrophages. Strains of EIAV exhibit differing cellular tropism. The Wyoming 
strain (WY) is a highly virulent wild type strain of EIAV, and its replication in vitro 
is restricted to equine macrophages in which it replicates to high titers. The WY 
strain was adapted to replicate in ED, FEK, FEA and CF12h cell lines and was 
termed the Malmquist strain (Malmquist et al., 1973). EIAV differs from other 
human and non-human lantiviruses in vivo in that it has not been found to infect 
lymphocytes; it is predominantly macrophage tropic (Clabough, 1990; Issel et al., 
1988). Pathogenically, EIA differs in several respects from other lentivirus 
infections, in that it does not induce direct immunosuppression (Montelaro et aI., 
1989), but circulating immune-complexes (Henson et al., 1973). 
2.5 Epidemiology of the Disease 
2.5.1 Occurrence 
EIA has been diagnosed in several different continents. In Europe, it is most 
prevalent in the northern and central regions. It has appeared in most states in the 
United States and the provinces of Canada but the principal enzootic areas are the 
Gulf Coast region and the northern wooded sections of Canada (Paquette, 1985). 
Diagnosis of the disease was made in Australia in 1959, but the incidence appears to 
be very low (Lepherd, 1981). The only area of Australia in which EIA could be 
regarded as being endemic is along the inland river systems of central and western 
Queensland. In a serological survey in this area in 1978, 21.7% of horses and 23% 
of properties were positive for EIAV (Thomas and Elder, 1978). The disease was 
also reported once in Thailand in 1996 and Mongolia (Vallat, 2003) (Appendix 1). 
The morbidity varies considerably and depends on the strain of the virus, and 
the inoculum delivered by the biting insects (Coggins, 1984). Extensive serological 
surveys over large areas, using the agar gel immunodiffusion (AGID) Coggins test 
have shown the prevalence rates, ranging from 1.5 - 2.5 % in the United States, to 
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50% in Brazil (Jenner and Romulo, 1994). The prevalence of infection varies 
depending on the population of horses, the proportion of carrier and the density of 
insect vectors (Hall et al., 1988). Large-scale movements of horses during wartime 
have been responsible for extensive dissemination of the disease. The possible 
detection of the infection at present is due to obligatory testing carried out. Rapid 
expansion of 'pleasure horse' activity in affluent countries may lead to more 
movement of horses and opportunities for spread of the infection from relatively few 
donors (Coggins, 1984). 
2.5.2 Methods of Transmission 
EIA virus is relatively resistant to most disinfectants and cannot be destroyed 
by boiling for 15 minutes, but is destroyed by sunlight. It persists for several months 
at room temperature in urine, feces, dried blood and serum. It is present in all 
tissues, secretions and excretions and may persist in the body for up to 18 years, 
providing a source of infection for most of the animal's life (Issel et al., 1988). 
Horses that are febrile and show clinical signs of EIA have a higher titer of viremia 
and much more likely to serve as a source of disease transmission than inapparent 
carriers (Kono, 1969; Issel et al., 1982; Orrego, 1983). 
Infection by the EIA virus usually occurs by transmission of blood between 
infected and uninfected horses, although body secretions may contain virus and 
could serve as a source of virus (Tshjian et al., 1984). Short - term contact is 
usually insufficient to cause spread, but continued, close association 
with susceptible animals usually results in infection. Spread within a group is slow, 
although occasionally fairly rapid spread is observed in large groups of horses 
assembled at racetracks or army depots (Clabough, 1990). 
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Insect vectors, the primary mode of transmission, with disease passage 
occurring through interrupted feeding of stable fly (Stomoxys calcitrans), deer flies 
(Chrysops spp.) and horse flies (Tabanus spp. and Hypomirta spp.) (Stein et al., 
1942; Hawkins et al., 1973, 1976; Kemen et al., 1978; Cupp and Kemen, 1980; Issel 
et al., 1982; Foil et al., 1983; Issel and Foil, 1984). The disease spreads most actively 
in summer and in marshy or wooded areas, suggesting that bites by insects may be 
the most important method of spread. It is probable that transmission is mechanical 
only (Cupp and Kemen, 1980; Issel and Foil, 1984). Therefore, wild type EIAV will 
not multiply in any species of insects (Shen et al., 1978; Williams et al., 1981). 
The virus has been transmitted under experimental and natural conditions from 
inapparently infected animals (Issel et al., 1982; Foil et al., 1988) where viremia 
titters are substantially lower than those observed in horses with clinical EIA (Kono 
et a1 1976; Issel et al., 1982). In enzootic areas, outbreaks have been caused by the 
use of untreated biological preparations of equine origin (Issel et al., 1988). 
Kemen and Coggins (1972) have reported intrauterine transmission. Foals 
have reportedly become infected through the milk of infected dams, but relatively 
large amounts of virus must be ingested to cause infection and the digestive tract is 
not a major portal of entry. Foals of infected dams are less susceptible to natural 
infection than adults possibly due partly to persistence of colostral antibodies (Foil et 
al., 1983). The opposite can also happen and the passively immune foal develops a 
fatal case of the acute disease (Issel et al., 1985). 
2.5.3 Risk Factors 
2.5.3.1 Environmental Factors 
There are marked seasonal incidence of the disease, most cases occurring in 
the summer and autumn. This is associated with low-lying and newly settled bush 
area and due to greater number of the insect vectors in such areas (Issel et al., 1992). 
Distances between horses are important to the carrier. Although tabanids are strong 
flyers, they usually prefer to complete an interrupted meal on the initial host or a 
nearby host (Foil, 1983). Prolonged therapy with corticosteroids and poor 
environment or management is known to induce recrudescence of EIA (Kono et al., 
1976). 
2.5.3.2 Animal Factors 
All breeds and age groups of equidae are susceptible to EIAV. The 
indigenous Criollo horses of Argentina are reported to be much more resistant to 
infection and only mildly affected by the disease (Shen et al., 1984). Foals have 
lower tabanid burdens than older horses due in part to their more vigorous defense 
movements (Issel et al., 1985; Foil et al., 1985). 
2.6 Pathogenesis 
After infection EIAV multiplies in tissues that have abundant macrophages, 
notably the liver, spleen, lymph nodes, lungs and kidney (Issel et al., 1988; Clabough 
1990) as viral replication occurs only in mature tissue of macrophages and does not 
occur in circulating monocytes (Maury 1994; Sellon et al., 1992). The acute form of 
the disease is thought to be associated with massive virus replication in and 
destruction of macrophages, but the actual cause of death is unknown. There is good 
evidence that the vascular lesions and the erythrocyte fragility are part of an immune 
reaction (Clabough 1990; Issel et al., 1988). 
2.7 Immune Reaction 
The immune response to EIAV is responsible for controlling replication of 
the virus and also plays an important role in the pathogenesis of the disease. The 
major clinical signs and lesions of EIA are attributable to the host response to the 
virus and not direct viral damage to the tissue (Sellon, 1993). Replication of EIAV 
stimulates a strong immune response that is detectable within 7 to 10 days of 
infection. Antibodies to the p26 core protein are detectable by AGID test in almost 
all horses 45 days after infection and by 60 days after infection antibodies to gp45 
and gp90 are present (Clabough, 1990). The immune response includes the 
production of virus neutralizing antibodies, complement-fixating antibodies, and 
cytotoxic T lymphocytes (McGuire et al., 1994). The immune responses are 
responsible for the termination of viremia, but this effect is not mediated by 
antibody-dependent cellular cytotoxicity against EIAV- infected macrophages 
(Tschetter et al., 1997). Virus-antibody complex are readily phagocytosed by cells 
of the reticulo-endothelial system, including tissue macrophages, and are involved in 
the development of the fever, depression, thrombocytopenia, anemia and 
glumerulonephritis, which are characteristic of the disease (Sellon, 1993). 
Infection with EIAV shortens the lifespan of circulating red blood cells to 
about 38 days (McGuire et al., 1969). EIAV also have suppressive effect on 
erythroid series cell in bone marrow (Swardson et al., 1992). The anemia caused by 
EIAV is not wholly due to the immune response of the host, but with severe 
combined immunodeficiency of the infection (Perryman et al., 1988). EIAV does not 
affect megakaryocytes and the suppressive effect of infection is due to at least in part 
to alpha and beta tumor necrosis factors (Crawford et al., 1996). 
2.8 Clinical Findings 
An incubation period of two to four weeks is usual in natural outbreaks of 
equine infectious anemia. Outbreaks usually follow a pattern of slow spread to 
susceptible horses after the introduction of an infected animal. After infection, the 
equine experiences three distinct disease phases: acute, chronic and inapparent 
carrier (Roberts and Lucas, 1987). 
Occasionally the initial attack is mild and may be followed by rapid clinical 
recovery. As a rule there is initial anorexia, depression, profound weakness, and loss 
of condition. Ataxia is a prominent sign in many cases and in some is recorded as the 
only clinical abnormality (McClure et al., 1982). There is intermittent fever (up to 
41 "C), which may rise and fall rapidly, sometimes varying as much as 1 "C within 1 
hour. Jaundice, oedema of the ventral abdomen, the prepuce and legs, and petechial 
hemorrhages in the mucosa, especially under the tongue and in the conjunctiva, may 
be observed. Pallor of the mucosa does not occur in this early stage and they tend to 
be congested and oedematous (Clabough, 1990). 
There is a characteristic increase in rate and intensity of the heart sounds, 
which are greatly exacerbated by moderate exercise. Myocarditis, manifested by 
tachycardia and arrhythmia, are described as being diagnostic. Respiratory signs are 
not marked, there is no dyspnea until the terminal stages, but there may be a thin 
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